Michael Wayne Kalb Catalyst Pharmaceuticals, Inc. (CPRX) insider trading activity

Michael Wayne Kalb is Executive Vice President & CFO of CATALYST PHARMACEUTICALS, INC.. Currently has a direct ownership of 4,197 shares of CPRX, which is worth approximately $96,195. The most recent transaction as insider was on Jan 02, 2025, when has been sold 2,941 shares (Common Stock, par value $0.001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.2K

n/a 3M change

n/a 12M change

Total Value Held $96,195

Michael Wayne Kalb Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jan 02 2025	SELL Payment of exercise price or tax liability	-	2,941 Reduced 41.2%	4,197 Common Stock, par valu...
Jan 02 2025	BUY Exercise of conversion of derivative security	-	7,138 Added 50.0%	7,138 Common Stock, par valu...

Also insider at

AMRN

AMARIN CORP PLCUK Healthcare

SVP and CFO

CINC

CinCor Pharma, Inc. Healthcare

EVP & Chief Financial Officer

IMPL

IMPEL PHARMACEUTICALS INC Healthcare

CFO

MWK